Zura Bio Limited - Class A (ZURA) closed at $1.24 on November 13, 2026, unchanged from the previous close, on volume of 4,149,430 shares (30-day average 6,734,834).
Data as of November 13, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 28, 2026 | Seagull With Call Spread | 20-Nov-264 P : 5 C : 7.5 C | 11,238 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
TipRanks (Thu, 12-Nov 5:45 PM ET)
Globe Newswire (Thu, 12-Nov 10:11 AM ET)
ACCESS Newswire (Wed, 11-Nov 10:15 AM ET)
PRNewswire (Tue, 10-Nov 10:09 AM ET)
ZURA Investors Have Opportunity to Join Zura Bio Limited Fraud Investigation with SBS Law
Business Wire (Tue, 10-Nov 8:33 AM ET)
TipRanks (Tue, 10-Nov 7:20 AM ET)
PRNewswire (Mon, 9-Nov 5:35 PM ET)
Why Is Zura Bio Stock (ZURA) Down 70% Today?
TipRanks (Mon, 9-Nov 2:55 PM ET)
Guggenheim Sticks to Their Buy Rating for Zura Bio (ZURA)
TipRanks (Mon, 9-Nov 8:56 AM ET)
Zura Bio Discontinues Hidradenitis Suppurativa Development After Trial Miss
TipRanks (Mon, 9-Nov 7:29 AM ET)
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
Zura Bio Limited - Class A trades on the NASDAQ stock market under the symbol ZURA.
As of November 13, 2026, ZURA stock price was flat at $1.24 with 4,149,430 million shares trading.
ZURA has a beta of -0.32, meaning it tends to be less sensitive to market movements. ZURA has a correlation of 0.00 to the broad based SPY ETF.
ZURA has a market cap of $119.44 million. This is considered a Micro Cap stock.
In the last 3 years, ZURA traded as high as $7.44 and as low as $.93.
The top ETF exchange traded funds that ZURA belongs to (by Net Assets): VXF, IWM, VTWO, IWO, FESM.
ZURA has underperformed the market in the last year with a price return of -73.2% while the SPY ETF gained +11.5%. ZURA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -78.5% and -67.8%, respectively, while the SPY returned -2.1% and -1.9%, respectively.
ZURA support price is $1.13 and resistance is $1.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ZURA shares will trade within this expected range on the day.
